Primary culture of human blood-retinal barrier cells and preliminary study of APOBEC3 expression: An in vitro study

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 9, 2009, Pages 4436-4443

  Lin, Haotian ^a   Zhang, Zhenping ^a   Zhang, Hui ^b   Yan, Pisong ^a   Wang, Qilin ^a   Bai, Ling ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3A; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3B; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3C; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3D; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE LIKE 3; GAMMA INTERFERON; HYDROLASE; PROTEIN APOBEC3; RNA; UNCLASSIFIED DRUG; APOBEC3 PROTEIN, HUMAN; CYTOSINE DEAMINASE; MESSENGER RNA;

ADULT; ARTICLE; BLOOD RETINA BARRIER; CAPILLARY ENDOTHELIUM; CELL ISOLATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PERICYTE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETINA; RETINA CAPILLARY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION; WESTERN BLOTTING; CAPILLARY; CELL SEPARATION; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; PHYSIOLOGY; RETINA BLOOD VESSEL; VASCULAR ENDOTHELIUM;

ADULT; BLOOD-RETINAL BARRIER; BLOTTING, WESTERN; CAPILLARIES; CELL CULTURE TECHNIQUES; CELL SEPARATION; CYTOSINE DEAMINASE; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; INTERFERON-GAMMA; PERICYTES; RETINAL PIGMENT EPITHELIUM; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 70349238790     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3169     Document Type: Article

References (33)

1. Dang Y, Wang X, Esselman WJ, Zheng YH. Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family. J Virol. 2006;80(21):10522-10533.
2. Delebecque F, Suspene R, Calattini S, et al. Restriction of foamy viruses by APOBEC cytidine deaminases. J Virol. 2006;80(2):605-614.
3. Harris RS, Bishop KN, Sheehy AM, et al. DNA deamination mediates innate immunity to retroviral infection. Cell. 2003;113(6):803-809.
4. Kobayashi M, Takaori-Kondo A, Shindo K, Abudu A, Fukunaga K, Uchiyama T. APOBEC3G targets specific virus species. J Virol. 2004;78(15):8238-8244.
5. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature. 2003;424(6944):99-103.
6. Mariani R, Chen D, Schrofelbauer B, et al. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell. 2003;114(1): 21-31.
7. Rosler C, Kock J, Kann M, et al. APOBEC-mediated interference with hepadnavirus production. Hepatology. 2005;42(2):301-309.
8. Russell RA, Wiegand HL, Moore MD, Schafer A, McClure MO, Cullen BR. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J Virol. 2005;79(14):8724-8731.
9. Sasada A, Takaori-Kondo A, Shirakawa K, et al. APOBEC3G targets human T-cell leukemia virus type 1. Retrovirology. 2005;2(1):32.
10. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 2002;418(6898):646-650.
11. Suspene R, Guetard D, Henry M, Sommer P, Wain-Hobson S, Vartanian JP. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc Natl Acad Sci U S A. 2005;102(23):8321-8326.
12. Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature. 2003;424(6944):94-98.
13. Marin M, Rose KM, Kozak SL, Kabat D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med. 2003;9(11):1398-1403.
14. Sheehy AM, Gaddis NC, Malim MH. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med. 2003;9(11):1404-1407.
15. Yu X, Yu Y, Liu B, et al. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science. 2003; 302(5647):1056-1060.
16. Zheng YH, Irwin D, Kurosu T, Tokunaga K, Sata T, Peterlin BM. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J Virol. 2004;78(11): 6073-6076.
17. Chen K, Huang J, Zhang C, et al. Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells. J Virol. 2006;80(15): 7645-7657.
18. Stopak KS, Chiu YL, Kropp J, Grant RM, Greene WC. Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J Biol Chem. 2007;282(6):3539-3546.
19. Argyris EG, Acheampong E, Wang FX, et al. The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system. J Virol. 2007;367(2):440-451.
20. Meyer JS, Katz ML, Maruniak JA, Kirk MD. Embryonic stem cellderived neural progenitors incorporate into degenerating retina and enhance survival of host photoreceptors. Stem Cells. 2006;24: 274-283.
21. Holland GN. AIDS and ophthalmology: the first quarter century. Am J Ophthalmol. 2008;145:397-408.
22. Antonetti DA, Wolpert EB. Isolation and characterization of retinal endothelial cells. Methods Mol Med. 2003;89:365-374.
23. Argyris EG, Acheampong E, Nunnari G, Mukhtar M, Williams KJ, Pomerantz RJ. Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts. J Virol. 2003;77(22):12140-12151.
24. Mukhtar M, Duke H, BouHamdan M, Pomerantz RJ. Anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells: an initial approach against a potential viral reservoir. Hum Gene Ther. 2000;11(2):347-359.
25. Mukhtar M, Harley S, Chen P, et al. Primary isolated human brain microvascular endothelial cells express diverse HIV/SIV-associated chemokine coreceptors and DC-SIGN and L-SIGN. Virology. 2002; 297(1):78-88.
26. Mukhtar M, Pomerantz RJ. Development of an in vitro blood-brain barrier model to study molecular neuropathogenesis and neurovirologic disorders induced by human immunodeficiency virus type 1 infection. J Hum Virol. 2000;3(6):324-334.
27. Snow C. Flow cytometer electronics. Cytometry A. 2004;57:63-69.
28. Anthony C, Mary EG. Simplified methods for consistent and selective culture of bovine retinal endothelial cells and pericytes. Invest Ophthalmol Vis Sci. 1990;31:1738-1744.
29. Herman IM, D'Amore PA. Microvascular pericytes contain muscle and nonmuscle actins. J Cell Biol. 1985;101:43.
30. Nayak RC, Berman AB, George KL, Eisenbarth GS, King GL. A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface. J Exp Med. 1988;167(3):1003-1015.
31. Boulton M. Melanin and the retinal pigment epithelium. In: Marmor MF, Wolfensberger T, eds. The Pigment Epithelium: Function and Disease. Oxford, UK: Oxford University Press; 1998:68-85.
32. Peng G, Lei KJ, Jin W, Greenwell-Wild T, Wahl SM. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J Exp Med. 2006;203(1): 41-46.
33. + T cells. Nature. 2005;435(7038):108-114.